ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Opinion

Japan should follow US efforts to develop new antibiotics

PASTEUR Act addresses growing health crisis of global significance

| Japan
A labo scientist holds up the basis for new antibiotic: innovative new antimicrobials are desperately needed.   © Reuters

Michael W. Hodin is CEO of the Global Coalition on Aging.

New legislation in the United States Congress is usually a routine occurrence, not a seminal event. But the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance, or PASTEUR, Act is different.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more